Symphony Robotics’ patent-pending know-how combines micro-robotic arms, real-time laptop imaginative and prescient, and AI. | Supply: Symphony Robotics
Symphony Robotics introduced Tuesday that it licensed micro-robotic arm know-how from Case Western Reserve College (CWRU).
Cleveland-based Symphony Robotics licensed CWRU’s novel, MRI-guided, magnetically actuated robotic platform. The know-how navigates non-linear trajectories, enabling exact, micro-invasive surgical procedures with real-time steerage.
The firm plans to advance the know-how that mixes micro-robotic arms, real-time laptop imaginative and prescient, and state-of-the-art AI. Its preliminary focus facilities round offering neurosurgeons with enhanced capabilities for advanced microsurgical procedures. They aim mind most cancers — significantly glioblastoma multiforme (GBM) — and epilepsy.
Finally, Symphony says it hopes to cut back incision and craniotomy dimension to lower than 4mm. This is able to mark a tenfold discount in comparison with present medical norms. The know-how may allow prolonged, exact entry to deep-seated lesions whereas defending the encircling tissue.
Register right now to avoid wasting 40% on convention passes!
The corporate constructed its ultra-maneuverable micro-robotic know-how to leverage MRI capabilities and allow real-time steerage. Its product stays investigational. This know-how is predicated on two proprietary developments: leveraging the magnetic capabilities of MRI methods for non-linear navigation of the micro robotic arms and enabling real-time steerage with MRI’s excessive decision imaging.
Symphony Robotics says it’s getting ready for nationwide testing in collaboration with main companion hospitals. This product isn’t out there for medical use and has not been cleared to be used by the US FDA.
Symphony targets GBM
GBM is among the many most aggressive and difficult mind cancers to deal with, the corporate says. Current surgical strategies, similar to craniotomies, are extremely invasive, requiring massive cranium openings and posing vital dangers. These embody trauma to wholesome mind tissue and delays in follow-up therapies similar to radiation, chemotherapy, or drug supply.
Different strategies similar to laser ablation solely assist a restricted and partial remedy choice. Symphony Robotics’ versatile, non-linear micro robotic arm goals to allow prolonged and exact entry to deep-seated lesions whereas defending surrounding eloquent tissue. This has the potential to enhance outcomes and high quality of life for GBM sufferers.
“Our know-how will introduce unprecedented developments in neurosurgery,” stated Mordechai (Moty) Avisar, Symphony Robotics founder and CEO. “The potential to reinforce surgical precision and enhance affected person outcomes is really groundbreaking. Neurosurgeons will be capable of carry out extremely focused procedures on deep-seated pathologies by considerably smaller surgical openings—right down to the micro degree—whereas navigating advanced, geometrically dispersed pathologies with higher security and accuracy.”
Editor’s Observe: This text was syndicated from The Robotic Report’s sibling web site MassDevice.
